Skip to content

Clinical trial of local installation of herbal eye drops in eyes for conjunctivitis

"Randomised Open Comparative Clinical Study Of Bilavadi Yoga Aschyotana And Triphala Kwatha Aschyotana In Vataj Abhishyanda W.S.R To Allergic Conjunctivitis"

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/02/049823
Enrollment
100
Registered
2023-02-17
Start date
Unknown
Completion date
Unknown
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H108- Other conjunctivitis Health Condition 2: H108- Other conjunctivitis

Interventions

None listed

Sponsors

Dr Sayali Sahebrao Rathod
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient of age group 16to 60years.Irresprctive of gender, religion,marital status.Unilateral and Bilateral vataj Abhishyanda

Exclusion criteria

Exclusion criteria: Patients having corneal involmemt .patient having complicated systemic diseases like RA SLE

Design outcomes

Primary

MeasureTime frame
To assess the decrease in symptoms of Vataj Abhishyanda in terms of subjective criteria like nistodana , sangharsh and netrastrava and in terms of objective criteria like raga,vartmashotha and shishirshrutaTimepoint: 4 weeks

Secondary

MeasureTime frame
1 To review the literature about Aschyotana 2 To review the literature about Vataj Abhishyanda 3 To review the literature about Allergic Conjunctivitis 4 To evaluate effect of Bilvadi yoga Aschyotana and Triphala kwatha Aschyotana In signs and symptoms of Vataj Abhishyanda 5 To evaluate the effect of Bilvadi yoga Aschyotana and Triphala kwatha Aschyotana In signs and symptoms of Allergic ConjunctivitisTimepoint: 18month

Countries

India

Contacts

Public ContactDr chandrashekhar mule

Maharashtra University of health sciences nashik

drcnm05@gmail.com9175800710

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026